Cargando…
Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study
CONTEXT: Glucocorticoid excess exhibits multiple detrimental effects by its catabolic properties. Metformin was recently suggested to protect from adverse metabolic side-effects of glucocorticoid treatment. Whether metformin is beneficial in patients with endogenous glucocorticoid excess has not bee...
Autores principales: | Vogel, Frederick, Braun, Leah, Rubinstein, German, Zopp, Stephanie, Oßwald, Andrea, Schilbach, Katharina, Schmidmaier, Ralf, Bidlingmaier, Martin, Reincke, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578886/ https://www.ncbi.nlm.nih.gov/pubmed/34777259 http://dx.doi.org/10.3389/fendo.2021.765067 |
Ejemplares similares
-
Signs, symptoms and biochemistry in recurrent Cushing disease: a prospective pilot study
por: Braun, Leah T., et al.
Publicado: (2021) -
Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess
por: Vogel, Frederick, et al.
Publicado: (2021) -
Persisting Muscle Dysfunction in Cushing’s Syndrome Despite Biochemical Remission
por: Vogel, Frederick, et al.
Publicado: (2020) -
Chemosensory dysfunction in Cushing’s syndrome
por: Heger, Elena, et al.
Publicado: (2021) -
E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess
por: Zhang, Wei, et al.
Publicado: (2023)